Target Gene/Pathway PATHWAY / GENE

  

Search results

No. KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG DRUG DrugBank 指定難病告示番号
1 SIGMAR1 2件: Amyotrophic lateral sclerosis 💬, Pathways of neurodegeneration - multiple diseases 💬 D00848 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
2 SIGMAR1 2件: Amyotrophic lateral sclerosis 💬, Pathways of neurodegeneration - multiple diseases 💬 D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
3 SIGMAR1 2件: Amyotrophic lateral sclerosis 💬, Pathways of neurodegeneration - multiple diseases 💬 D03744 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
4 CYSLTR1 2件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 D00529 Montelukast 8件: 6, 13, 46, 61, 63, 85, 98, 228
5 CYSLTR1 2件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬 D08229 Montelukast 8件: 6, 13, 46, 61, 63, 85, 98, 228
6 HRH3 1件: Neuroactive ligand-receptor interaction 💬 D09870 Bavisant 1件: 6
7 HRH3 1件: Neuroactive ligand-receptor interaction 💬 D10749 Pitolisant 3件: 6, 113, 193
8 CHRM1 8件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00397 Tropicamide 3件: 6, 13, 19
9 CHRM1 8件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00465 Oxybutynin 3件: 6, 13, 53
10 CHRM1 8件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00722 Oxybutynin 3件: 6, 13, 53
11 CHRM1 8件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00787 Trihexyphenidyl 2件: 5, 6
12 CHRM1 8件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D02212 Ipratropium 2件: 6, 86
13 CHRM1 8件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D08638 Trihexyphenidyl 2件: 5, 6
14 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00397 Tropicamide 3件: 6, 13, 19
15 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00465 Oxybutynin 3件: 6, 13, 53
16 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00525 Pilocarpine 3件: 6, 53, 299
17 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00722 Oxybutynin 3件: 6, 13, 53
18 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00787 Trihexyphenidyl 2件: 5, 6
19 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D02200 Pilocarpine 3件: 6, 53, 299
20 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D02212 Ipratropium 2件: 6, 86
21 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D05478 Pilocarpine 3件: 6, 53, 299
22 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D07226 Fesoterodine 1件: 6
23 CHRM2 6件: Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D08638 Trihexyphenidyl 2件: 5, 6
24 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00397 Tropicamide 3件: 6, 13, 19
25 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00465 Oxybutynin 3件: 6, 13, 53
26 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00525 Pilocarpine 3件: 6, 53, 299
27 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00722 Oxybutynin 3件: 6, 13, 53
28 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00787 Trihexyphenidyl 2件: 5, 6
29 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D01269 Solifenacin 3件: 6, 13, 53
30 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D01699 Darifenacin 2件: 6, 13
31 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D02200 Pilocarpine 3件: 6, 53, 299
32 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D02212 Ipratropium 2件: 6, 86
33 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D03654 Darifenacin 2件: 6, 13
34 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D05478 Pilocarpine 3件: 6, 53, 299
35 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D07226 Fesoterodine 1件: 6
36 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D08522 Solifenacin 3件: 6, 13, 53
37 CHRM3 11件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Taste transduction 💬, Regulation of actin cytoskeleton 💬, Insulin secretion 💬, Salivary secretion 💬, Gastric acid secretion 💬, Pancreatic secretion 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D08638 Trihexyphenidyl 2件: 5, 6
38 CHRM4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00397 Tropicamide 3件: 6, 13, 19
39 CHRM4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00465 Oxybutynin 3件: 6, 13, 53
40 CHRM4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00722 Oxybutynin 3件: 6, 13, 53
41 CHRM4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D00787 Trihexyphenidyl 2件: 5, 6
42 CHRM4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D02212 Ipratropium 2件: 6, 86
43 CHRM4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬 D08638 Trihexyphenidyl 2件: 5, 6
44 CHRM5 6件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00397 Tropicamide 3件: 6, 13, 19
45 CHRM5 6件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00465 Oxybutynin 3件: 6, 13, 53
46 CHRM5 6件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00722 Oxybutynin 3件: 6, 13, 53
47 CHRM5 6件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D00787 Trihexyphenidyl 2件: 5, 6
48 CHRM5 6件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D02212 Ipratropium 2件: 6, 86
49 CHRM5 6件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Regulation of actin cytoskeleton 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬 D08638 Trihexyphenidyl 2件: 5, 6
50 CHRNA1 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
51 CHRNA1 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
52 CHRNA1 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
53 CHRNA2 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
54 CHRNA2 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
55 CHRNA2 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
56 CHRNA3 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Chemical carcinogenesis - receptor activation 💬 D03365 Nicotine 3件: 6, 13, 84
57 CHRNA3 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Chemical carcinogenesis - receptor activation 💬 D05156 Nicotine 3件: 6, 13, 84
58 CHRNA3 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Chemical carcinogenesis - receptor activation 💬 D05157 Nicotine 3件: 6, 13, 84
59 CHRNA4 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D03365 Nicotine 3件: 6, 13, 84
60 CHRNA4 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D05156 Nicotine 3件: 6, 13, 84
61 CHRNA4 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D05157 Nicotine 3件: 6, 13, 84
62 CHRNA4 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D08669 Varenicline 2件: 6, 18
63 CHRNA5 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
64 CHRNA5 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
65 CHRNA5 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
66 CHRNA7 7件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D03365 Nicotine 3件: 6, 13, 84
67 CHRNA7 7件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D05156 Nicotine 3件: 6, 13, 84
68 CHRNA7 7件: Calcium signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D05157 Nicotine 3件: 6, 13, 84
69 CHRNB1 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
70 CHRNB1 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
71 CHRNB1 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
72 CHRNB2 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D03365 Nicotine 3件: 6, 13, 84
73 CHRNB2 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D05156 Nicotine 3件: 6, 13, 84
74 CHRNB2 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D05157 Nicotine 3件: 6, 13, 84
75 CHRNB2 4件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Nicotine addiction 💬, Chemical carcinogenesis - receptor activation 💬 D08669 Varenicline 2件: 6, 18
76 CHRNB3 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
77 CHRNB3 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
78 CHRNB3 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
79 CHRNB4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Chemical carcinogenesis - receptor activation 💬 D03365 Nicotine 3件: 6, 13, 84
80 CHRNB4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Chemical carcinogenesis - receptor activation 💬 D05156 Nicotine 3件: 6, 13, 84
81 CHRNB4 3件: Neuroactive ligand-receptor interaction 💬, Cholinergic synapse 💬, Chemical carcinogenesis - receptor activation 💬 D05157 Nicotine 3件: 6, 13, 84
82 CHRND 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
83 CHRND 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
84 CHRND 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
85 CHRNE 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
86 CHRNE 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
87 CHRNE 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
88 CHRNG 1件: Neuroactive ligand-receptor interaction 💬 D03365 Nicotine 3件: 6, 13, 84
89 CHRNG 1件: Neuroactive ligand-receptor interaction 💬 D05156 Nicotine 3件: 6, 13, 84
90 CHRNG 1件: Neuroactive ligand-receptor interaction 💬 D05157 Nicotine 3件: 6, 13, 84
91 CLCN2 1件: Mineral absorption 💬 D04790 Lubiprostone 4件: 6, 13, 290, 299
92 CNR1 4件: Rap1 signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Thermogenesis 💬, Retrograde endocannabinoid signaling 💬 D05099 Nabilone 2件: 6, 13
93 CNR1 4件: Rap1 signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Thermogenesis 💬, Retrograde endocannabinoid signaling 💬 D10915 Cannabidiol 19件: 2, 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
94 CNR2 1件: Neuroactive ligand-receptor interaction 💬 D05099 Nabilone 2件: 6, 13
95 CNR2 1件: Neuroactive ligand-receptor interaction 💬 D10915 Cannabidiol 18件: 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
96 COMT 4件: Steroid hormone biosynthesis 💬, Tyrosine metabolism 💬, Metabolic pathways 💬, Dopaminergic synapse 💬 D00781 Entacapone 2件: 6, 17
97 COMT 4件: Steroid hormone biosynthesis 💬, Tyrosine metabolism 💬, Metabolic pathways 💬, Dopaminergic synapse 💬 D00786 Tolcapone 3件: 6, 28, 127
98 COMT 4件: Steroid hormone biosynthesis 💬, Tyrosine metabolism 💬, Metabolic pathways 💬, Dopaminergic synapse 💬 D10825 Opicapone 1件: 6
99 ADORA1 7件: cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Sphingolipid signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Regulation of lipolysis in adipocytes 💬, Renin secretion 💬, Morphine addiction 💬 D00528 Caffeine 9件: 2, 6, 13, 21, 46, 78, 96, 97, 265
100 ADORA1 7件: cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Sphingolipid signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Regulation of lipolysis in adipocytes 💬, Renin secretion 💬, Morphine addiction 💬 D01453 Caffeine 9件: 2, 6, 13, 21, 46, 78, 96, 97, 265
101 ADORA2A 7件: Rap1 signaling pathway 💬, Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Parkinson disease 💬, Alcoholism 💬 D00528 Caffeine 9件: 2, 6, 13, 21, 46, 78, 96, 97, 265
102 ADORA2A 7件: Rap1 signaling pathway 💬, Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Parkinson disease 💬, Alcoholism 💬 D01453 Caffeine 9件: 2, 6, 13, 21, 46, 78, 96, 97, 265
103 ADORA2A 7件: Rap1 signaling pathway 💬, Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Parkinson disease 💬, Alcoholism 💬 D04641 Istradefylline 1件: 6
104 ADORA2A 7件: Rap1 signaling pathway 💬, Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Parkinson disease 💬, Alcoholism 💬 D09717 Preladenant 1件: 6
105 ADORA2A 7件: Rap1 signaling pathway 💬, Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Vascular smooth muscle contraction 💬, Parkinson disease 💬, Alcoholism 💬 D10174 Tozadenant 1件: 6
106 CSF2RA 4件: Cytokine-cytokine receptor interaction 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, Pathways in cancer 💬 D05803 Sargramostim 7件: 6, 28, 60, 62, 96, 229, 285
107 CSF3R 5件: Cytokine-cytokine receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Hematopoietic cell lineage 💬, Pathways in cancer 💬 D03235 Filgrastim 34件: 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331
108 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D00255 Carvedilol 5件: 6, 57, 86, 113, 210
109 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D00610 Terazosin 1件: 6
110 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D01277 Droxidopa 5件: 5, 6, 17, 169, 170
111 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D01307 Midodrine 3件: 6, 17, 58
112 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D02268 Ergoloid mesylate 2件: 6, 206
113 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D02349 Dipivefrin 1件: 6
114 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D03415 Carvedilol 5件: 6, 57, 86, 113, 210
115 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D08220 Midodrine 3件: 6, 17, 58
116 ADRA1D 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D08569 Terazosin 1件: 6
117 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D00255 Carvedilol 5件: 6, 57, 86, 113, 210
118 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D00610 Terazosin 1件: 6
119 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D01277 Droxidopa 5件: 5, 6, 17, 169, 170
120 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D01307 Midodrine 3件: 6, 17, 58
121 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D02268 Ergoloid mesylate 2件: 6, 206
122 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D02349 Dipivefrin 1件: 6
123 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D03415 Carvedilol 5件: 6, 57, 86, 113, 210
124 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D08220 Midodrine 3件: 6, 17, 58
125 ADRA1B 6件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D08569 Terazosin 1件: 6
126 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D00255 Carvedilol 5件: 6, 57, 86, 113, 210
127 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D00610 Terazosin 1件: 6
128 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D01277 Droxidopa 5件: 5, 6, 17, 169, 170
129 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D01307 Midodrine 3件: 6, 17, 58
130 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D01965 Silodosin 2件: 6, 13
131 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D02268 Ergoloid mesylate 2件: 6, 206
132 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D02349 Dipivefrin 1件: 6
133 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬, Vascular smooth muscle contraction 💬, Salivary secretion 💬 D03415 Carvedilol 5件: 6, 57, 86, 113, 210
134 ADRA1A 7件: Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, AMPK signaling pathway 💬, Adrenergic signaling in cardiomyocytes 💬,